Chronic Obstructive Pulmonary Diseases:Journal of the COPD Foundation

Editorial Board

Articles submitted to Chronic Obstructive Pulmonary Diseases: the Journal of the COPD Foundation will undergo rigorous peer review. Once accepted, articles will be published online rapidly. The COPD Foundation is proud to have assembled an international editorial board featuring leaders in the field of COPD.


Editor in Chief

  • Mark  Dransfield, MD

    Mark Dransfield, MD
    Editor in Chief

    Birmingham, AL, USA


Mark Dransfield is currently the William C. Bailey Endowed Chair in Pulmonary Disease and Professor of Medicine in the Division of Pulmonary, Allergy and Critical Care at the University of Alabama at Birmingham (UAB) and staff physician at the Birmingham VA Medical Center. In addition, he serves as the Medical Director of the UAB Lung Health Center.

Dr. Dransfield’s primary clinical and research interest is COPD and directs the UAB/Centers for Medicare and Medicaid COPD Bundled Payments for Care Improvement (BPCI) initiative. He is principal investigator for multiple translational studies and clinical trials at the UAB Lung Health Center including the Department of Defense-sponsored Beta-Blockers for the Prevention of Acute Exacerbations of COPD study as well as the National Institutes of Health-sponsored COPDGene and SPIROMICS studies.

He completed his medical degree at the University of North Carolina at Chapel Hill followed by residency in internal medicine and fellowship in pulmonary and critical care at UAB where he served as chief fellow.

Dr. Dransfield has been named one of America’s Best Doctors from 2010 to 2018. He is active with the American Thoracic Society and the American College of Chest Physicians.

Publication/Editorial Experience

Dr. Dransfield has published over 125 research papers focusing on COPD-related epidemiology, comorbid illness, pathophysiology and therapeutics.

He has been a reviewer for over 20 different peer-reviewed journals including the New England Journal of Medicine, American Journal of Respiratory and Critical Care Medicine, Lancet, Thorax and Chest.

Before becoming an editor of Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation, he served on its editorial board from its inception in 2014. He served as a Section Editor for the BMC Pulmonary Medicine journal from 2013-2016.


  • M. Bradley Drummond, MD, MHS

    M. Bradley Drummond, MD, MHS
    Editor

    Chapel Hill, NC, USA


Michael Bradley (Brad) Drummond is an Associate Professor of Medicine in the Division of Pulmonary Diseases and Critical Care Medicine at the University of North Carolina, Chapel Hill School of Medicine where he also serves as Director of the Obstructive Lung Diseases Clinical and Translational Research Center.

Dr. Drummond’s clinical expertise includes COPD, alpha-1 antitrypsin deficiency, and smoking cessation. With an expertise in epidemiology and clinical trial design, he has focused his translational and clinical research on understanding the pattern and risk factors for lung function progression in smokers as well as HIV-infected individuals. His primary project is a National Heart Lung and Blood Institute-funded study of a novel biomarker in the blood and lungs of individuals with or at-risk for COPD and examining the role of vitamin D on levels of this biomarker.

He completed his medical degree from the University of Texas Southwestern School of Medicine followed by a residency in internal medicine and a fellowship in pulmonary and critical care medicine at Johns Hopkins Hospital and School of Medicine, where he served as chief resident.

Dr. Drummond is active with the American College of Chest Physicians and a Fellow and Mentor with the American Thoracic Society. He is also a member of the COPD Foundation’s Medical and Scientific Advisory Board.

Publications/Editorial Experience

Dr. Drummond has served as a reviewer for many peer-reviewed journals including the New England Journal of Medicine, the Journal of the American Medical Association, the American Journal of Respiratory and Critical Care Medicine, Thorax and the Annals of Internal Medicine where he was recognized as being in the “Top 10 Percent of Reviewers.” He has served as an associate editor for BMC Pulmonary Medicine and Chronic Obstructive Pulmonary Diseases: Journal of COPD and is currently on the Editorial Board of Annals of the American Thoracic Society. Before becoming an Editor for Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation, he served on its Editorial Board from its inception in 2014.

 

  • Maria Rosa Faner, PhD

    MARIA ROSA FANER, PhD
    Editor

    Barcelona, Spain


Maria “Rosa” Faner is the Serra Hunter Professor of Immunology at the Universitat de Barcelona, Spain.

Dr. Faner’s primary research focus is understanding the clinical and immunological heterogeneity of chronic respiratory diseases such as COPD. Within this framework, her main areas of expertise relate to the vital lung function trajectories in COPD, the application of network medicine tools to study the heterogeneity of COPD, and the immunological aspects of COPD both at the molecular and cellular levels.

Dr. Faner holds a Master of Science in biology and a PhD in immunology from the University Autónoma de Barcelona, Spain. Her completed fellowships include: the Catalan Ministry of Science student fellowship, the Beatriu de Pinos Blood and Tissue Bank (Barcelona) post-doctoral fellowship, the Miguel Servet Research Fellowship with the Spanish National Health System, a research fellowship with the European Respiratory Society and the Dyason Research Fellowship at the University of Melbourne.

She has also served as a post-doctoral researcher with the Fundació Privada Clinic in Barcelona, CIMERA in Illes Balears, and CIBERES in Barcelona and as a visiting scientist at the Channing Division of Network Medicine at Harvard University, Boston.

Dr. Faner is active with the European Respiratory Society and has been a frequent invited presenter at the Society’s annual congress in addition to presenting at the American Thoracic Society’s International Conference, among others.

Publications/Editorial Experience

Dr. Faner has published extensively in the world’s top cited journals with extensive international collaboration.

 

  • Ken Kunisaki, MD, MS

    Ken Kunisaki, MD, MS
    Editor

    Minneapolis, MN, USA


Ken Kunisaki, MD, MS, is currently a staff physician at the Minneapolis Veterans Affairs (VA) Health Care System and Associate Professor of Medicine in the Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine at the University of Minnesota.

Dr. Kunisaki’s research interests are primarily in clinical trials, observational cohort studies, and international team-based science. COPD studies have been a primary focus throughout his investigative career, ranging from epidemiologic investigations to early-phase, hypothesis-generating pilot studies to multi-center randomized controlled trials. His other National Institutes of Health (NIH) and VA-funded research areas include sleep apnea, respiratory infections (such as influenza and COVID-19), and HIV-associated lung and sleep disorders.

Dr. Kunisaki received his medical degree from Ohio State University, followed by residency (internal medicine and pediatrics), fellowship (adult pulmonary and critical care medicine) and a Master of Science in Clinical Research degree at the University of Minnesota, where he remains on faculty. His full-time clinical practice is at the Minneapolis VA, where he directs the COPD Case Management Program, performs navigational bronchoscopy procedures, and attends on the pulmonary consultation teaching service.

Dr. Kunisaki is a fellow of the American Thoracic Society, and his other professional activities include serving on clinical trial data safety and monitoring boards and serving on grant review study sections for the NIH and VA.

Publications/Editorial Experience

Prior to becoming an Editor for Chronic Obstructive Pulmonary Diseases: the Journal of the COPD Foundation, Dr. Kunisaki served on the journal’s editorial board since its founding in 2014. He is also on the editorial board of HIV Medicine, and he is a regular reviewer for peer-reviewed medical journals in general medicine, respiratory medicine, sleep medicine, and HIV and infectious diseases.

 

  • Fanny Wai San Ko, MD

    Fanny Wai San Ko, MD
    Editor

    Hong Kong


Fanny Wai San Ko, MD, is a specialist respiratory physician consultant in the Department of Medicine and Therapeutics at Prince of Wales Hospital in Hong Kong. She is also the Honorary Clinical Associate Professor of the Faculty of Medicine at the Chinese University of Hong Kong.

Dr. Ko’s main research interest is in asthma and COPD. She is currently studying the outcome of patients with asthma and COPD, including those with an overlap of the diseases. In addition, she is performing research on exhaled nitric oxide and the microbiome of asthma patients.

Dr. Ko graduated from the Chinese University of Hong Kong. After her graduation, she completed full training in internal and respiratory medicine at the Prince of Wales Hospital in Hong Kong. With the support of the Croucher Foundation Scholarship and the Hong Kong Lung Foundation Fellowship, she also completed a year of research training in the Woolcock Institute of Medical Research at the University of Sydney in Australia.

Dr. Ko is currently a member of the Scientific Committee of the Global Initiative for Asthma (GINA), Vice-chairman of Hong Kong Lung Foundation and Medical Advisor of the Hong Kong Asthma Society. In addition, she is a Past President of the Hong Kong Thoracic Society.

Publications/Editorial Experience

Dr. Ko has published more than 160 papers in peer reviewed journals. She has been the Senior Editor of Respirology since 2013 and an Associate Editor for the International Journal of Tuberculosis and Lung Disease since 2019.

In addition, Dr. Ko has served as a reviewer for the American Journal of Respiratory and Critical Care Medicine, Thorax, Clinical Experimental Allergy, Respirology, BMC Pulmonary Medicine, the International Journal of Tuberculosis and Lung Disease, Respiratory Medicine, Respiration, International Archives of Allergy and Immunology and PLOS One.

 

  • Valerie Press, MD, MPH

    Valerie Press, MD, MPH
    Editor

    Chicago, IL, USA


Valerie Press is an Associate Professor of Medicine and Pediatrics and Medical Director of the Care Transitions Clinic at the University of Chicago. Dr. Press received her medical degree and Master of Public Health in health management and policy degree at the University of Michigan in Ann Arbor. She completed her internal medicine and pediatrics residency training and health services research fellowship training at the University of Chicago.

Dr. Press' research is focused on developing, testing, and implementing patient and system level interventions to improve the quality and value of care for patients with chronic lung disease across care transition settings. She currently serves as principal investigator for a Research Project grant (R01) from the National Institutes of Health’s National Heart, Lung, and Blood Institute and as principal investigator on an Innovation Award from the American Lung Association, both focused on improving care for patients with COPD by reducing revisits to the emergency department and/or hospital after a hospitalization for COPD exacerbations.

Dr. Press is a Fellow of the American Thoracic Society (ATS), the American College of Physicians, and the American Academy of Pediatrics, and she is a Senior Fellow of the Society of Hospital Medicine. She is active with each of these societies and the COPD Foundation, serving on the Advisory Board for the Foundation’s health care provider initiative, PRAXIS—Prevent and Reduce COPD Admissions Through Expertise and Innovations Sharing. Dr. Press received the ATS’ Early Career Achievement Award in 2020.

Publications/Editorial Experience

Dr. Press has authored or coauthored nearly 100 manuscripts in peer-reviewed journals. In addition to serving as an Editor of Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation, Dr. Press is also an Associate Editor for the Journal of General Internal Medicine. Dr. Press serves on the editorial boards of Annals of American Thoracic Society, CHEST (COPD team), and Frontiers in Medicine-Pulmonary Medicine (Review Editor).

 

  • Nirupama Putcha, MD, MHS

    Nirupama Putcha, MD, MHS
    Editor

    Baltimore, MD, USA


Nirupama (Niru) Putcha, MD, MHS, is an Assistant Professor of Medicine in the Division of Pulmonary and Critical Care Medicine at Johns Hopkins University School of Medicine.

Dr. Putcha’s clinical expertise includes obstructive lung diseases, specifically COPD. She is a member of the Johns Hopkins Bridging Research, Lung Health and the Environment (BREATHE) Center which seeks to understand the intersection between the environment and health outcomes in obstructive lung diseases in Baltimore. As a member of the BREATHE center she has focused her clinical research on understanding the importance of environmental exposures including allergens and pollutants as well as comorbid chronic disease on health outcomes in individuals with COPD. Her primary projects seek to look at allergen sensitization and exposure and risk for adverse outcomes in COPD, as well as the role of home environmental exposures on risk for readmission in individuals with COPD recently hospitalized for exacerbations.

She completed her medical degree from the University of Alabama at Birmingham followed by residency in internal medicine at the Hospital of the University of Pennsylvania and fellowship in pulmonary and critical care medicine at Johns Hopkins, where she completed a Masters in Epidemiology at the Johns Hopkins Bloomberg School of Public Health.

Dr. Putcha is a member of the American Thoracic Society, where she is active in the Clinical Problems and the Environmental Occupational and Public Health Assemblies. She also serves as faculty in the ATS “Methods in Epidemiologic, Clinical, and Operations Research (MECOR)” program course in India.

Publications/Editorial Experience

Dr Putcha has served as a reviewer for many peer-reviewed journals including the American Journal of Respiratory and Critical Care Medicine, Thorax, Annals of the American Thoracic Society, and Chest. She has served as Associate Editor for BMC Pulmonary Medicine. Before becoming an Editor for Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation, she served on its Editorial Board from its inception in 2014.

 

  • James D. Crapo, MD

    James D. Crapo, MD
    Founding Editor

    Denver, CO, USA


Dr. James Crapo is currently a Professor of Medicine at the University of Colorado-Denver and National Jewish Health where he also served as the Chairman of the Department of Medicine and Executive Vice President for Academic Affairs from 1996 until 2004. In addition, he served as Chief of the Division of Pulmonary and Critical Care Medicine at Duke University for 17 years, following training at the Los Angeles Harbor General Hospital, Duke University and the National Institute of Environmental Health Sciences.

Dr. Crapo maintains an active research program focused in two areas: (1) Development of metalloporphyrin antioxidant mimetics as a new therapeutic in the fields of cancer radiation therapy, idiopathic pulmonary fibrosis, organ transplantation, and neurologic diseases, and (2) Serving as co-principal investigator of COPDGene, a National Heart Lung and Blood Institute (NHLBI)-funded multi-center project to follow a cohort of more than 10,000 individuals who have a significant smoking history and are at risk for or have COPD.

Dr. Crapo is a former President of the American Thoracic Society and the Fleischner Society. He is a Fellow of the American College of Physicians and the American College of Chest Physicians. He is a member of the American Society of Clinical Investigation and the Association of American Physicians. Dr. Crapo has served as the Chair of the National Heart Lung and Blood Institute (NHLBI) Pulmonary Disease Advisory Committee and as a Member of Council for the NHLBI, and he currently serves as a member of the NHLBI Board of External Advisors.

Publications/Editorial Experience

Dr. Crapo has authored over 300 published peer-reviewed articles and 48 book chapters. He is the author of 10 pulmonary textbooks.

Prior to becoming the Editor in Chief of Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation, he served as Editor of COPD: Journal of Chronic Obstructive Pulmonary Disease for 10 years and as an Associate Editor for Experimental Lung Research and the American Journal of Respiratory Cell and Molecular Biology. He has also served on the Editorial Boards of the American Review of Respiratory Diseases, Inhalation Toxicology, the Journal of Allergy and Clinical Immunology and the American Journal of Physiology: Lung Cellular and Molecular Physiology.

 

Editorial Board

  • Alvar Agusti, MD, PhD, FRCP, FERS
    Thorax Institute at Hospital Clinic, Spain

  • Zaurbeck R. Aisanov
    Pulmonology Research Institute, Russia

  • Antonio Anzueto, MD
    University of Texas Health Science Center, San Antonio, TX, USA

  • Kristina Bailey, MD
    University of Nebraska Medical Center, Omaha, NE, USA

  • Ronald Balkissoon, MD, MSc, DIH, FRCPC
    National Jewish Health, Denver, CO, USA

  • Roberto Benzo, MD
    Mayo Clinic, Rochester, MN, USA

  • Surya P. Bhatt, MD
    University of Alabama at Birmingham, Birmingham, AL

  • P.Sherwood Burge, MD
    Birmingham Heartlands Hospital, United Kingdom

  • Robert Burkes, MD, MSCR
    University of Cincinnati, Cincinnati, OH, USA

  • Peter Calverley, FMedSci
    University Hospital Aintree, United Kingdom

  • Richard Casaburi, MD, PhD, M.Eng
    Los Angeles Biomedical Research Institute, Los Angeles, CA, USA

  • Bart Celli, MD
    Brigham and Women’s Hospital, Boston, MA, USA

  • James D. Chalmers, MBChB, PhD
    University of Dundee, Ninewells Hospital, United Kingdom

  • Kenneth Chapman, MD, FRCPC, FACP, FCCP
    Toronto Western Hospital, Canada

  • William Checkley, MD, PhD
    Johns Hopkins University, Baltimore, MD, USA

  • Stephanie A. Christenson, MD
    University of California, San Francisco, CA, USA

  • Dawn DeMeo, MD, MPH
    Brigham and Women’s Hospital, Boston, MA, USA

  • Anthony DeSoyza, MBChB, BMSC, PhD
    Newcastle University, United Kingdom

  • Leonardo Fabbri, MD
    University of Modena and Reggio Emilia, Italy

  • Marilyn Foreman, MD, MS
    Morehouse School of Medicine, Atlanta, GA, USA

  • Roger Goldstein, MBChB, FCCP
    West Park Health Center, Canada

  • Nicola Hanania, MD, MS
    Baylor College of Medicine, Houston, TX, USA

  • Craig Hersh, MD
    Brigham and Women’s Hospital, Boston, MA, USA

  • Kylie Hill, PhD
    Curtin University, Australia

  • Jerry Krishnan, MD, PhD
    University of Minnesota, Minneapolis, MN, USA

  • Wassim Labaki, MD
    University of Michigan, Ann Arbor, MI, USA

  • David LaFon, MD
    University of Alabama at Birmingham, Birmingham, AL

  • David Lomas, MBB, MRCP, FRCR
    University College London, United Kingdom

  • David Lynch, MB
    National Jewish Health, Denver, CO, USA

  • Donald Mahler, MD
    Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA

  • Marc Miravitlles, MD, FERS
    Hospital Universitari Vall d’Hebron, Spain

  • Zab Mosenifar, MD
    Cedars-Sinai Medical Center, Los Angeles, CA, USA

  • Michael Niederman, MD
    Weill Cornell Medical College, New York, NY, USA

  • Koichi Nishimura, MD
    National Center for Geriatrics/Gerontology, Japan

  • Yeon-Mok Oh, MD
    University of Ulsan College of Medicine, South Korea

  • Jill Ohar, MD
    Wake Forest Baptist Medical Center, Winston-Salem, NC, USA

  • Michael I. Polkey, PhD
    Royal Brompton & Harefield NHS Foundation Trust, United Kingdom

  • Stephen Rennard, MD
    University of Nebraska Medical Center, Omaha, NE, USA

  • Bruce Rubin, MEngr, MD, MBA
    Virginia Commonwealth University, Richmond, VA, USA

  • Robert Sandhaus, MD, PhD
    National Jewish Health, Denver, CO, USA

  • Sanjay Sethi, MD
    University of Buffalo, Buffalo, NY, USA

  • Edwin Silverman, MD, PhD
    Brigham and Women’s Hospital, Boston, MA, USA

  • Don Sin, MD, MPH
    James Hogg Research Centre, Canada

  • Dave Singh, MD
    University of Manchester, United Kingdom

  • James Stoller, MD, MS
    Cleveland Clinic, Cleveland, OH, USA

  • Charlie Strange, MD
    Medical University of South Carolina, Charleston, SC, USA

  • Wan-Cheng Tan, MD
    University of British Columbia, Canada

  • Donald Tashkin, MD
    David Geffen School of Medicine, Los Angeles, CA, USA

  • Byron Thomashow, MD
    Columbia University School of Medicine, New York, NY, USA

  • Alice Turner, MBChB, MRCP, PGCE, PhD
    Queen Elizabeth Hospital Research Laboratories, United Kingdom

  • Omar Usmani, MBBS, PhD, FHEA, FRCP
    Imperial College London, United Kingdom

  • Claus Vogelmeier, MD
    University of Marburg, Germany

  • George R. Washko, MD
    Brigham and Women’s Hospital, Boston, MA, USA

  • Jadwiga Wedzicha, MD
    Imperial College, United Kingdom

  • J. Michael Wells, MD
    University of Alabama, Birmingham, AL, USA

  • Christine Wendt, MD
    University of Minnesota, Minneapolis, MN, USA

  • Xin Xu, MD, PhD
    University of Alabama at Birmingham, Birmingham, AL, USA

  • Barbara Yawn, MD
    Olmstead Medical Center, Rochester, MN, USA